Additional file 14: Figure S7. of Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer Melissa Quintero Douglas Adamoski Larissa Reis Carolline Ascenção Krishina Oliveira Kaliandra Gonçalves Marília Dias Marcelo Carazzolle Sandra Dias 10.6084/m9.figshare.c.3924763_D5.v1 https://springernature.figshare.com/articles/figure/Additional_file_14_Figure_S7_of_Guanylate-binding_protein-1_is_a_potential_new_therapeutic_target_for_triple-negative_breast_cancer/5580928 GO analysis of altered pathways in TNBC tissues and cell lines (compared with non-TNBC samples). Biological processes (blue), cellular components (red) and molecular functions (green) equally enriched in TNBC tissues (left) and cell lines (right). These pathways point to events occurring on the membrane, associated with signaling activity and cell motility. Each box denotes 1 order of magnitude of FDR reduction; dashed black lines highlight an FDR = 0.05 (PNG 1759 kb) 2017-11-07 05:00:00 Breast cancer Triple-negative breast cancer Gene expression RNA-Seq Transcriptomics Therapeutic target